Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-17 Purchase | 2026-06-22 10:30 am | Pasithea Therapeutics Corp. | KTTA | Coastlands Capital LP 10% Owner | 100,000 | $0.53 | $53,000 | 3,835,035 (Indirect) | View |
| 2025-11-28 Purchase | 2025-12-01 09:07 am | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 133,333 | $0.75 | $100,000 | 199,691 (Direct) | View |
| 2025-11-28 Purchase | 2025-12-01 08:56 am | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 33,333 | $0.75 | $25,000 | 73,334 (Direct) | View |
| 2025-11-28 Purchase | 2025-12-01 08:54 am | Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director | 33,333 | $0.75 | $25,000 | 35,833 (Direct) | View |
| 2025-05-12 Sale | 2025-05-14 9:55 pm | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 960 | $0.825 | $792 | 40,001 (Direct) | View |
| 2023-06-02 Purchase | 2023-06-06 9:00 pm | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 30,000 | $0.431 | $12,930 | 1,327,174 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-01 Option Award | 2026-05-05 4:42 pm | N/A 2036-04-30 | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 1,756,069 | $0 | 1,756,069 (Direct) | View |
| 2026-05-01 Option Award | 2026-05-05 4:42 pm | N/A 2036-04-30 | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 152,783 | $0 | 152,783 (Direct) | View |
| 2026-05-01 Option Award | 2026-05-05 4:41 pm | N/A 2036-04-30 | Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director | 152,783 | $0 | 152,783 (Direct) | View |
| 2026-05-01 Option Award | 2026-05-05 4:41 pm | N/A 2036-04-30 | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 1,129,323 | $0 | 1,129,323 (Direct) | View |
| 2026-05-01 Option Award | 2026-05-05 4:41 pm | N/A 2036-04-30 | Pasithea Therapeutics Corp. | KTTA | Krishnan Kartik Chief Medical Officer | 1,129,323 | $0 | 1,129,323 (Direct) | View |
| 2026-05-01 Option Award | 2026-05-05 4:41 pm | N/A 2036-04-30 | Pasithea Therapeutics Corp. | KTTA | Leahy Emer Director | 152,783 | $0 | 152,783 (Direct) | View |
| 2026-05-01 Option Award | 2026-05-05 4:40 pm | N/A 2036-04-30 | Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director | 152,783 | $0 | 152,783 (Direct) | View |
Ownership | 2026-04-17 9:45 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Coastlands Capital LP 10% Owner | 0 | $0 | 14,968,369 (Indirect) | View |
| 2025-11-28 Option Award | 2025-12-01 09:04 am | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 26,667 | $0.75 | 26,667 (Direct) | View |
| 2025-11-28 Option Award | 2025-12-01 08:51 am | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Leahy Emer Director | 33,333 | $0.75 | 33,333 (Direct) | View |
| 2025-10-24 Option Award | 2025-10-27 5:27 pm | N/A 2035-10-23 | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 242,913 | $0 | 242,913 (Direct) | View |
| 2025-10-24 Option Award | 2025-10-27 5:27 pm | N/A 2035-10-23 | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 317,266 | $0 | 317,266 (Direct) | View |
| 2025-10-24 Option Award | 2025-10-27 5:26 pm | N/A 2035-10-23 | Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director | 42,913 | $0 | 42,913 (Direct) | View |
| 2025-10-24 Option Award | 2025-10-27 5:26 pm | N/A 2035-10-23 | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 493,341 | $0 | 493,341 (Direct) | View |
| 2025-10-24 Option Award | 2025-10-27 5:26 pm | N/A 2035-10-23 | Pasithea Therapeutics Corp. | KTTA | Leahy Emer Director | 42,913 | $0 | 42,913 (Direct) | View |
| 2025-10-24 Option Award | 2025-10-27 5:25 pm | N/A 2035-10-23 | Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director | 42,913 | $0 | 42,913 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:25 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director | 2,750 | $5.62 | 3,500 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 5:25 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director | 750 | $5.61 | 3,500 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 26,669 | $0 | 26,669 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 15,927 | $0 | 15,927 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Leahy Emer Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Currie Graeme Martin Chief Development Officer | 5,938 | $0 | 5,938 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:47 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:46 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 15,927 | $0 | 15,927 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:46 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:46 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 26,669 | $0 | 26,669 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:46 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Leahy Emer Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Currie Graeme Martin Chief Development Officer | 5,938 | $0 | 5,938 (Direct) | View |
Ownership | 2023-07-03 5:00 pm | 2023-06-30 2033-02-23 | Pasithea Therapeutics Corp. | KTTA | Currie Graeme Martin Chief Development Officer | 0 | $0 | 300,000 (Direct) | View |